NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Agrenvec

Agrenvec

Private
MadridHealthcare & Life Scienceshttps://www.agrenvec.es/

Last Round

Grant

Feb 26, 2025

Total Funding Raised

$1.26M

Company Overview

Agrenvec is a biotechnology company that specializes in the plant-based manufacturing of high-quality recombinant human proteins for skincare, diagnostics, research, and biotechnological applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

recombinant proteinsmolecular farminganimal-free proteinsplant-based expressioncultivated meatgrowth factorscontract manufacturingbiomanufacturingrecombinant reagentslab-grown meatendotoxin-freetransient expressionNicotiana benthamianabiotech reagentsalternative protein

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Agrenvec Comps

Public and private peers based on sector, stage, and business model.

Agrenvec comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Agrenvec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 26, 2025
GrantDec 30, 2022
Series AApr 27, 2010

Agrenvec Investors

Notable investors and investment history

Agrenvec Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Agrenvec Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Agrenvec's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadrid
Employee Range15
Year Founded2002
Last FundingFeb 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.